Virtual White Boards for Patient Satisfaction

NCT04497922 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-01-27

No results posted yet for this study

Summary

Communication with patients on their clinical status is important in delivering care in the emergency department. During times of high volume or complex patients, there may be lapses in communicating with patients about their hospital course or plans of action. These miscommunications may be enhanced during the current COVID-19 pandemic as there is minimized in-person interaction with patients in order to conserve personal protective equipment and decrease the risk of disease transmission. This study utilizes a virtual white board to deliver updates to patients about the status of their emergency department stay.

Conditions

  • Satisfaction, Patient
  • Covid19
  • Emergencies
  • Satisfaction
  • Information Disclosure

Interventions

DEVICE

e-ink screen

A virtual display screen developed by e-ink that displays patient status, basic demographics, care team information, pending tests and anticipated disposition

BEHAVIORAL

Treatment as usual

Treatment as usual in the emergency department with communication of testing results, imaging and disposition by the primary clinical emergency department team.

Sponsors & Collaborators

  • E-ink corporation

    collaborator UNKNOWN
  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Peter R Chai, MD MMS · Brigham and Women's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-25
Primary Completion
2021-04-30
Completion
2021-05-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04497922 on ClinicalTrials.gov